)
)
Intra-Cellular Therapies Investor Relations Material
Latest events
Q3 2024
Intra-Cellular Therapies
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Intra-Cellular Therapies Inc
Access all reports
Intra-Cellular Therapies Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for central nervous system disorders. The company develops therapies targeting neuropsychiatric and neurological conditions using its proprietary research platform. Its product portfolio includes both marketed treatments and pipeline candidates addressing various mental health and neurological diseases. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Intra-Cellular Therapies Inc
Study Result
Intra-Cellular Therapies Inc
Study Result
Intra-Cellular Therapies Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
ITCI
Country
🇺🇸 United States